Trigometric Launches NumisArt, the World’s First Numismatic NFT Trading Platform
Malaysia’s largest collectible auctioneer leverages on blockchain technology to add a new dimension to numismatic collecting and trading KUALA LUMPUR,...
Malaysia’s largest collectible auctioneer leverages on blockchain technology to add a new dimension to numismatic collecting and trading KUALA LUMPUR,...
Let Arlo’s advanced monitoring devices watch over your doorstep and protect your delivery packages SINGAPORE - Media OutReach - 12...
Acquisition of cloud-native payments technology firm to modernize infrastructure and create greater flexibility for the firm’s merchant acquiring capabilities globally...
The international conference to discuss innovation, the key to solving global warming with experts from industry, academia, and government from...
Celregen Obtains the Exclusive Rights to Develop, Manufacturing and Commercialize CLS001 in Greater China Region; Cellusion Retains Other Regional Rights....
TAIPEI, TAIWAN - Media OutReach - 12 September 2022 - As the wave of new digital technologies continues to sweep...
SHANGHAI/SINGAPORE - Media OutReach - 12 September 2022 - TXPC (Shanghai) Network Technologies Co., Ltd ("TXPC") and the Singapore-based company,...
DUBAI, UAE - Media OutReach - 12 September 2022 - BeaRex, a vibrant blockchain runner that has combined GameFi's Free2Play...
The partnership will help boost contact center employee morale and provide superior customer experiences using Conversational AI and Automation HO...
SINGAPORE - Media OutReach - 12 September 2022 - Oasys, an environmentally-friendly, gaming-optimised Proof-of-Stake blockchain built for gamers by gamers,...
WUHU, China--(BUSINESS WIRE)--China celebrates the Mid-Autumn Festival on September 10. On this day, all Chinese families will partake in eating...
DESTINY-Lung02 phase 2 trial shows clinically meaningful efficacy and favorable safety at 5.4 mg/kg dose versus 6.4 mg/kg dose of...
Extended follow-up data from phase 1/2 trial of DS-7300 in patients with metastatic lung, prostate or esophageal cancer to be...
Tislelizumab demonstrated non-inferiority for overall survival and favorable safety profile versus sorafenib in global Phase 3 trial Additional poster presentations...
HONG KONG--(BUSINESS WIRE)--#insurance--AM Best has revised the implications of the under review status to positive from developing for the Financial...